Carvedilol Dosing
For chronic heart failure, start carvedilol at 3.125 mg twice daily and uptitrate every 2 weeks to a target dose of 25 mg twice daily (or 50 mg twice daily for patients >85 kg), taken with food. 1, 2
Heart Failure Dosing Algorithm
Starting dose: 3.125 mg twice daily with food 3, 4, 1, 2
Uptitration schedule:
- Double the dose every 2 weeks minimum if the previous dose is well tolerated 3, 1
- Progression: 3.125 mg → 6.25 mg → 12.5 mg → 25 mg twice daily 3, 1
- Target dose: 25 mg twice daily (or 50 mg twice daily for patients >85 kg) 3, 1
Monitoring during titration:
- Heart rate, blood pressure, clinical status (symptoms, signs of congestion, body weight) 1
- Check blood chemistry at 1-2 weeks after initiation and 1-2 weeks after final dose titration 1
Key principle: Some beta-blocker is better than no beta-blocker—use the highest tolerated dose even if target cannot be reached 1
Post-Myocardial Infarction with LV Dysfunction
Starting dose: 6.25 mg twice daily 2
Uptitration:
- Increase after 3-10 days (based on tolerability) to 12.5 mg twice daily, then to target of 25 mg twice daily 2
- May use lower starting dose (3.125 mg twice daily) if clinically indicated (low BP, low HR, fluid retention) 2
- Start only after patient is hemodynamically stable and fluid retention minimized 2
Hypertension
Starting dose: 6.25 mg twice daily 5, 6, 2
Uptitration:
- Maintain for 7-14 days, then increase to 12.5 mg twice daily if needed 2
- Can further increase to 25 mg twice daily if tolerated 2
- Maximum: 50 mg total daily dose 5, 6, 2
- Use standing systolic pressure measured 1 hour after dosing as tolerance guide 2
Special Populations
Elderly patients (>75 years):
- Use same dosing as general population 3
- No specific dose adjustment required, but monitor closely for hypotension and bradycardia 5, 6
Hepatic impairment:
- Severe hepatic impairment: CONTRAINDICATED 2
- Mild-moderate impairment: Use with caution, consider slower uptitration (no specific dose provided in guidelines)
Renal impairment:
- No specific dose adjustment required 1
- Monitor for worsening renal function but do not discontinue for mild deterioration 7
Critical Management Points
Problem-solving during titration: 1
- Worsening congestion: Double diuretic dose first; if ineffective, halve carvedilol dose
- Marked fatigue/bradycardia: Halve carvedilol dose (rarely necessary to discontinue)
- Hypotension: Reduce vasodilator doses first before reducing carvedilol
- Bradycardia (HR <55 bpm): Reduce dose 2
When to seek specialist consultation: 1
- NYHA Class IV severe heart failure
- Current or recent (within 4 weeks) decompensation requiring hospitalization
- Heart block or HR <60/min
- Persistent signs of congestion (elevated JVP, ascites, marked peripheral edema)
Absolute contraindications: 3, 1
- Asthma bronchiale
- Severe bronchial disease
- Symptomatic bradycardia or hypotension
Administration Essentials
- Always take with food to slow absorption and reduce orthostatic effects 2
- Never discontinue abruptly—taper over 1-2 weeks to avoid rebound effects, especially in coronary artery disease 2
- Carvedilol is specifically proven to reduce mortality in heart failure; benefits cannot be assumed as a class effect of all beta-blockers 3, 1
Common pitfall: Providers often fail to uptitrate to target doses. In real-world data, only 18.7% of eligible patients receive target beta-blocker doses 7. Aggressive uptitration to target doses is essential for mortality benefit—do not settle for subtherapeutic dosing without attempting full titration.